Treace Medical Concepts Reports Third Quarter 2024 Financial Results
Revenue for the third quarter of 2024 was $45.1 million, representing an increase of 11% compared to $40.8 million in the third quarter of 2023. The increase was driven by product mix shift that resulted from increased adoption of newer technologies and increased sales of ancillary products used in bunion cases and an increase in active surgeons.
Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 7.41% and 3.11%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview For Treace Medical Concepts
With 3 analyst ratings, Treace Medical Concepts has a consensus rating of Neutral. The average one-year price target is $6.83, indicating a potential 42.89% upside.
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic
Teradata Reports Third Quarter 2024 Financial Results
Teradata (NYSE: TDC) today announced its third quarter 2024 financial results. "In the third quarter, we grew our cloud business, delivered innovations that strengthen our market position, and added new customers and partners.
Tri-County Financial Group, Inc. Reports Third Quarter 2024 Financial Results
Tri-County Financial Group, Inc. (The Company) (OTCQX: TYFG) today announced financial results for the third quarter of 2024.
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...
kjrh.com5d
Oklahoma's Cold Case Files: Gregory Treace
News' Sharon Phillips' latest Cold Case investigation looks into the story of Gregory Treace who's been missing from Creek ...
SFGate1d
Treace Medical Concepts: Q3 Earnings Snapshot
PONTE VEDRA, Fla. (AP) — PONTE VEDRA, Fla. (AP) — Treace Medical Concepts Inc. (TMCI) on Tuesday reported a loss of $15.4 million in its third quarter. The Ponte Vedra, Florida-based company said it ...
TMCnet5d
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI) investors concerning the Company's possible violations ...
Stockhouse3d
Treace Medical Concepts Inc Is Being Looked Into By The Schall Law Firm For Securities Fraud And Affected Investors Are Encouraged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace ...
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
The Nanoplasty™ MIS System is designed to deliver a reproducible 3D correction of the bunion deformity through a cosmetically appealing, hidden incision on the side of the foot and help patients get ...
TMCnet5d
The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI) on behalf of investors concerning the Company's possible ...